Based on previous studies which showed a correlation between high plasma GDF15 and poor treatment response in ovarian cancer patients,11 we measured the GDF15 plasma concentration following short- and long-term carboplatin treatment in A2780 and A2780cis tumor-bearing mice (Fig. S3). This evidence concerns the gene GDF15 and ovarian carcinoma.